Corteva, Inc. (NYSE:CTVA) Shares Acquired by Corient Private Wealth LLC

Corient Private Wealth LLC grew its stake in Corteva, Inc. (NYSE:CTVA) by 4.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 224,732 shares of the company’s stock after purchasing an additional 10,259 shares during the quarter. Corient Private Wealth LLC’s holdings in Corteva were worth $12,801,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CTVA. Quest Partners LLC purchased a new stake in Corteva during the 3rd quarter valued at about $587,000. Pathstone Holdings LLC grew its stake in Corteva by 3.0% during the 3rd quarter. Pathstone Holdings LLC now owns 98,919 shares of the company’s stock valued at $5,815,000 after acquiring an additional 2,846 shares in the last quarter. Prospera Financial Services Inc grew its stake in Corteva by 3.5% during the 3rd quarter. Prospera Financial Services Inc now owns 6,687 shares of the company’s stock valued at $393,000 after acquiring an additional 226 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its stake in Corteva by 13.1% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 10,101 shares of the company’s stock valued at $594,000 after acquiring an additional 1,172 shares in the last quarter. Finally, Banque Cantonale Vaudoise grew its stake in Corteva by 234.1% during the 3rd quarter. Banque Cantonale Vaudoise now owns 19,952 shares of the company’s stock valued at $1,173,000 after acquiring an additional 13,981 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Buying and Selling

In related news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares of the company’s stock, valued at $723,257.78. This represents a 70.07 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.20% of the stock is owned by insiders.

Corteva Stock Performance

Shares of CTVA stock opened at $62.50 on Thursday. The firm’s 50 day moving average price is $62.25 and its 200-day moving average price is $59.79. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a one year low of $50.01 and a one year high of $66.24. The firm has a market cap of $42.85 billion, a P/E ratio of 48.45, a P/E/G ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s payout ratio is currently 52.71%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. BNP Paribas raised shares of Corteva to a “hold” rating in a research note on Monday, February 10th. KeyCorp upped their price objective on shares of Corteva from $68.00 to $70.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. UBS Group decreased their target price on shares of Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a report on Friday, January 10th. The Goldman Sachs Group initiated coverage on shares of Corteva in a report on Thursday, March 13th. They issued a “buy” rating and a $71.00 target price on the stock. Finally, Royal Bank of Canada boosted their target price on shares of Corteva from $72.00 to $73.00 and gave the company an “outperform” rating in a report on Friday, February 7th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $68.00.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.